CSL
Director Trades
| Date | Director | Value |
|---|---|---|
| 16/3/25 | M. Clark | $50,012 |
Company News
Want to buy some cut-price shares?
What would your reaction be if I told you I could get you some shares at a price that is significantly less than what they are actually worth? Well, most people would say here is a wheelbarrow, fill it up with shares but as always there is something of a catch. It is possible to […]
CSL reports 25% profit increase as immunoglobulins and plasma collections lead growth
Biotherapeutics giant CSL (ASX: CSL) has reported a net profit after tax of US$2.64 billion for the 12 months to 30 June, up 25% on a constant currency basis. Net profit after tax before amortisation was US$2.91b (up 15% on a constant currency basis), while revenue for the year was up 11% to US$14.8b. Total […]
CSL profits take US$250m hit from foreign currency movements
Foreign currency movements have dented the forecast profits of multi-national biotechnology company CSL (ASX: CSL) by up to US$250 million. The company this week reported higher-than-expected headwinds, up from an estimated US$175 million reported at the time of its half year results in February. Its constant currency profit guidance for the year remains unchanged, albeit […]
Rio Tinto advances Turquoise Hill takeover, CSL to gain new boss and Telstra issues apology
Rio Tinto’s (ASX: RIO) share price fell at the start of the week, despite a positive update on its proposed takeover of Canadian miner Turquoise Hill Resources. The mining giant announced it received the required support from Turquoise Hill shareholders for its proposed acquisition of the remaining 49% the Canadian miner’s issued and outstanding common […]
Ventia awarded NZ road maintenance contract, CSL to acquire Vifor Pharma and A2 Milk closer to exporting to US
Ventia Services (ASX: VNT) has been awarded a road maintenance contract by Auckland Transport for New Zealand’s Auckland West region. The contract term is for five years and is set to commence on 1 September and generate a base value of NZ$220 million across the initial term. It has an option to be extended for […]
Magellan appoints new CEO, TPG sells mobile towers and Orica boss raises fears over energy security
Magellan Financial Group (ASX: MFG) has announced the appointment of a new chief executive officer in David George, six months on from Brett Cairns deciding to walk away from the job. Magellan chairman Hamish McLennan is full of praise for Mr George, saying he has an “outstanding investment management pedigree”. “The board was unanimous in […]
Ramsay Health Care receives takeover bid, Westpac fined again, iron ore giants miss production targets
Investors in Ramsay Health Care (ASX: RHC) are buoyant this week after news was released global private equity giant KKR & Co Inc have launched a $20 billion takeover of the institution. Since news of the deal broke, shares in Ramsay have risen just over 24% to sit at $80. A group of investors, led […]
Macquarie sells Axicom, Telstra first female CEO, Pilbara Minerals continues to gain
ASX-listed majors across banking, telecommunications, biotechnology and mining posted a solid performance this week, with investment banking giant Macquarie Group (ASX: MQG) selling its stake in Axicom in a transaction worth US$2.68 billion (A$3.58 billion). Owned by a consortium led by Macquarie Infrastructure and Real Assets, UniSuper and UBS, Axicom was sold to a telecom […]
Where to buy defensive stocks at the right price
If the coronavirus were an Olympic athlete, it would be smashing the best-ever marathon time by taking a sneaky short cut, or else heaving to a weightlifting record with a belly full of steroids. Yep – the vexatious virus is not playing by the rules, which puts paid to the notion that ‘recovery’ stocks such […]